|Source||Humanized (from mouse)|
|Chemical and physical data|
|Molar mass||77.3 kg/mol g·mol−1|
|(what is this?)|
Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, a ribosome inactivating protein from the plant Bougainvillea spectabilis. It has undergone pre-clinical trials for the treatment of ovarian cancer and other solid tumors.
- International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
- Viventia Biotech Inc.: VB6-845 Archived 2010-03-29 at the Wayback Machine
|This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|